about
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasRecurrent activating ACVR1 mutations in diffuse intrinsic pontine gliomaA comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis.Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Learning a Markov Logic network for supervised gene regulatory network inferenceHistone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesCell microarrays in drug discovery.The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal diseaseCo-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.Dynamic binding of RBPJ is determined by Notch signaling status.Quantitative analysis of highly parallel transfection in cell microarrays.New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis.Large scale RNAi screen reveals that the inhibitor of DNA binding 2 (ID2) protein is repressed by p53 family member p63 and functions in human keratinocyte differentiationIntegrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.Histone H3 genotyping refines clinico-radiological diagnostic and prognostic criteria in DIPG.Multimodal Magnetic Resonance Imaging of Treatment-Induced Changes to Diffuse Infiltrating Pontine Gliomas in Children and Correlation to Patient Progression-Free Survival.Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?Cerebral blood flow changes after radiation therapy identifies pseudo-progression in diffuse intrinsic pontine gliomas.Systematic identification of suspected anthelmintic benzimidazole metabolites using LC-MS/MS.Small-RNA sequencing identifies dynamic microRNA deregulation during skeletal muscle lineage progression.Cell microarray for functional exploration of genomes.K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway.Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.Diagnostics of Paediatric Supratentorial RELA Ependymomas: Integration of information from Histopathology, Genetics, DNA Methylation and ImagingTranscriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial locationReciprocal signalling by Notch-Collagen V-CALCR retains muscle stem cells in their nicheInternational experience in the development of patient-derived xenograft models of diffuse intrinsic pontine gliomaAn integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN).Id2 reverses cell cycle arrest induced by {gamma}-irradiation in human HaCaT keratinocytes[Cell microarrays and functional genomics]A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survivalHigh Prevalence of Developmental Venous Anomaly in Diffuse Intrinsic Pontine Gliomas: A Pediatric Control StudyNotch-Induced miR-708 Antagonizes Satellite Cell Migration and Maintains QuiescenceTP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)
P50
Q24339074-A965198D-6268-4CE0-ADA9-09BE20ADB3FEQ28237518-C598984D-4E10-417F-B353-FC0044442E33Q30567356-A9A955F3-8B90-44F5-BB43-96B18AA1B0E3Q33803137-BA3D71DF-7BCA-4084-95B6-B79EF17FA531Q34985897-ED559393-405A-48DA-9CBB-3612F9FC6941Q36303824-5CB78455-4EA4-454A-9331-52B1C12E6E2BQ36515799-3BC86338-9E21-46DE-90B1-438D96980262Q37553466-8B7E616B-FBB2-4C24-AE90-4C4442F2D127Q37736041-C811164D-76C6-4FD5-82CE-5389E38847EEQ39094276-F0954C51-5C75-4552-83D9-19010E41CB89Q39155079-5CDBC241-1069-4300-8CF5-BAD2E714C821Q40553449-4B6FADB1-514E-467A-8A4D-2E6386F28DCAQ41592783-B2272186-F18C-4383-8885-A858BB096343Q42112906-C3AA5801-50C1-40D6-B1E5-F69DF0078940Q42375231-07A7C87E-9FDA-495B-B494-E8FBD44A0D52Q42875399-22590942-F0E2-43C1-B867-A81D65EC7069Q48034862-C344F2EE-EE7E-40AA-9827-DAE8F7AF69AEQ48190337-BA7E821F-EF6D-4C25-A727-487609FC3982Q49825613-19DBE88C-DDB6-47B8-9F63-7B833E6A6A9BQ50064963-982C7450-AB5E-4CB4-B6C8-F6D0E3FCD9AAQ50420105-082F3001-0849-45E2-A42A-E985352E8310Q50658688-336A0706-96AD-4E93-8295-4B0C6FBFC8BDQ53201539-13D33E70-CB2A-4C82-8D87-7ADE149980A6Q55456557-976EC837-3878-4519-A67C-9EB35A8E7F4EQ57456192-D5690D4E-E26B-4831-87FC-CBB2B741B230Q58609134-07C93356-C4AA-4C0E-A843-86E507E29AA9Q59059802-4689F267-3FE7-42B2-A327-FDD4BE168892Q63722737-EFDA441E-79A2-4F6C-A2D1-095F2A2DF12BQ64905059-A570E1C1-B2A3-4B72-B98C-9BFF4486165DQ81362544-F0269D8D-F1E0-4B49-A606-30531E07E87DQ81733136-E42973EE-6386-43DC-8E21-172E6E5C1392Q92035715-8FDB5A54-B839-415B-90F7-6397471747D9Q92159797-9A1CB032-EC41-470D-92F4-40C1AA987DF1Q92985050-6158FD30-7F53-4823-B40E-FEA167C39179Q93085775-9ABCA943-D6FE-46FA-9E95-C72A999DDA07
P50
description
researcher ORCID ID = 0000-0003-0247-080X
@en
wetenschapper
@nl
name
David Castel
@ast
David Castel
@en
David Castel
@es
David Castel
@nl
type
label
David Castel
@ast
David Castel
@en
David Castel
@es
David Castel
@nl
prefLabel
David Castel
@ast
David Castel
@en
David Castel
@es
David Castel
@nl
P214
P106
P21
P214
P31
P496
0000-0003-0247-080X
P734
P735
P7859
viaf-218449069